Home/Clinical Trials, Industry News, Interstitial Cystitis Network Blog, Research/New Bladder Pain Treatment In Development – IC Clinical Trial

New Bladder Pain Treatment In Development – IC Clinical Trial

Banner_IC_300x250_7The Interstitial Cystitis Network is pleased to inform you that a research study is now enrolling women between the ages of 18 and 75 who have IC/BPS. This study will assess the effectiveness of an oral investigational study medicine (AQX-1125) to see if it will reduce the moderate to severe IC/BPS pain being experienced by study participants.

  • If you were disqualified from another study focusing on IC/BPS, you may qualify for this new study.
  • If you participated in another study focusing on IC/BPS, you may be able to enroll in this study if more than 90 days has passed since the last study.

If you qualify for participation in this IC/BPS study, you may:

  • Learn more about your IC/BPS and ways to manage it
  • Receive at no cost to you study-related medical tests, procedures, and medicines
  • Be reimbursed for study-related travel costs or have transportation provided

There is no cost to you, and you can participate even if:

  • Your health insurance network is different from the study doctor
  • You do not have health insurance

Contact Information:

To see if you pre-qualify and receive more information about this research study, please visit our study website!

CLICK HERE TO LEARN MORE ABOUT THE STUDY
Best Regards,

IC Network

By | 2017-01-31T12:39:07+00:00 July 22nd, 2014|Clinical Trials, Industry News, Interstitial Cystitis Network Blog, Research|Comments Off on New Bladder Pain Treatment In Development – IC Clinical Trial

About the Author:

My Google Profile+ Jill Heidi Osborne is the president and founder of the Interstitial Cystitis Network, a health education company dedicated to interstitial cystitis, bladder pain syndrome and other pelvic pain disorders. As the editor and lead author of the ICN and the IC Optimist magazine, Jill is proud of the academic recognition that her website has achieved. The University of London rated the ICN as the top IC website for accuracy, credibility, readability and quality. (Int Urogynecol J - April 2013). Harvard Medical School rated both Medscape and the ICN as the top two websites dedicated to IC. (Urology - Sept 11). Jill currently serves on the Congressionally Directed Medical Research Panel (US Army) where she collaborates with researchers to evaluate new IC research studies for possible funding. Jill has conducted and/or collaborates on a variety of IC research studies on new therapeutics, pain care, sexuality, the use of medical marijuana, menopause and the cost of treatments, shining a light on issues that influence patient quality of life. An IC support group leader and national spokesperson for the past 20 years, she has represented the IC community on radio, TV shows, at medical conferences. She has written hundreds of articles on IC and its related conditions. With a Bachelors Degree in Pharmacology and a Masters in Psychology, Jill was named Presidential Management Intern (aka Fellowship) while in graduate school. (She was unable to earn her PhD due to the onset of her IC.) She spends the majority of her time providing WELLNESS COACHING for patients in need and developing new, internet based educational and support tools for IC patients, including the “Living with IC” video series currently on YouTube and the ICN Food List smartphone app! Jill was diagnosed with IC at the age of 32 but first showed symptoms at the age of 12.